confirmatory clinical trial
Term · Oncology and biomedicine · MLC-T-ONC-001992
A study that confirms how well a new treatment works after it was shown in early-phase clinical trials that it might be beneficial for patients. New drugs that are given an accelerated approval by the U.S. Food and Drug Administration (FDA) to treat a serious or life-threatening disease, such as cancer, are required to be tested in a confirmatory clinical trial. This is done to verify that they really work when they are tested on many more people in a randomized study. The FDA may remove a drug from the market if a confirmatory clinical trial shows that the drug is not beneficial for patients.
| Identifier | MLC-T-ONC-001992 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001992",
"term": "confirmatory clinical trial",
"field": "Oncology and biomedicine",
"definition": "A study that confirms how well a new treatment works after it was shown in early-phase clinical trials that it might be beneficial for patients. New drugs that are given an accelerated approval by the U.S. Food and Drug Administration (FDA) to treat a serious or life-threatening disease, such as cancer, are required to be tested in a confirmatory clinical trial. This is done to verify that they really work when they are tested on many more people in a randomized study. The FDA may remove a drug from the market if a confirmatory clinical trial shows that the drug is not beneficial for patients.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/confirmatory-clinical-trial/"
}
Record 5,205 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.